Skip to main content

Germany

07
May 2020

German DRG system change in 2020

Since January 1, 2020, the nursing staff costs of the hospitals are excluded from the DRG case flat rates and financed in parallel to the DRG case flat rates using a hospital-specific care budget based on the principle of cost coverage.
23
Apr 2020

Cervical cancer screening: new billing regulations in Germany

The revised EBM (German Uniform Evaluation Standard) comes into force on April 1, 2020. Among others, the amendments made concern the billing of the services within the framework of early detection of cervical cancer. Also, the new fee order item (GOP) for the human papillomaviruses (HPV) genotyping service was added.
16
Apr 2020

Glioblastoma therapy with tumor-treating fields will be available in Germany

Patients with a newly diagnosed glioblastoma will have an opportunity to benefit from the therapy with tumor-treating fields (TTF) at the expense of statutory health insurance. The Federal Joint Committee (G-BA) decided on March 20, 2020, the details concerning the indications and the quality assurance measures that will apply when prescribing this outpatient treatment method.
26
Mar 2020

IQWiG defines five new topics for HTA reports in Germany

On March 13, 2020, the Institute for Quality and Efficiency in Health Care (IQWiG) announced that the new HTA reports would concern cystitis, heart disease in children, social isolation, as well as vitamin B12 / vitamin D deficiency in the elderly, and the Feldenkrais Method in treatment of mobility disorders.
12
Mar 2020

Liposuction in severe cases will be reimbursed in Germany

In severe cases of lipedema, the costs for liposuction will be covered by the statutory health insurance companies from January 2020. The National Association of Statutory Health Insurance Physicians (KBV) and the National Association of Statutory Health Insurance Funds (GKV) have added several new fee order items to the EBM (German Uniform Evaluation Standard) and set the reimbursement.
02
Mar 2020

New reimbursement code for 2019-nCoV testing added to EBM catalog in Germany

On the 1st of February, 2020, the National Association of Statutory Health Insurance Physicians (KBV) and the National Association of Statutory Health Insurance Funds (GKV-SV) have made the agreement for laboratory diagnostic clarification about the novel coronavirus. Afterwards, the statutory health insurance companies will cover the costs of the test for the novel coronavirus (2019-nCoV) if there are justified suspected cases.